Using Molecular Dynamics Simulations to Evaluate Active Designs of Cephradine Hydrolase by Molecular Mechanics/Poisson-Boltzmann Surface Area and Molecular Mechanics/generalized Born Surface Area Methods
Overview
Authors
Affiliations
The poor predictive accuracy of current computational enzyme design methods has led to low success rates of producing highly active variants that target non-natural substrates. In this report, a quantitative assessment approach based on molecular dynamics (MD) simulations was developed to eliminate false-positive enzyme designs at the computational stage. Taking cephradine hydrolase as an example, the apparent Michaelis binding constant ( ) and catalytic efficiency ( / ) of designed variants were correlated with binding free energies and activation energy barriers, respectively, as calculated by molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) and molecular mechanics/generalized Born surface area (MM/GBSA) methods with explicit water considered based on general MD simulation protocols. The correlation results showed that both the MM/GBSA and MM/PBSA methods with a protein dielectric constant ( = 4) could rank the variants well based on the predicted binding free energies between enzyme and the substrate. Furthermore, the activation energy barriers calculated by the MM/PBSA method with an = 24 correlated well with / . Thus, false-positive variants obtained by the enzyme design program PRODA were eliminated prior to experimentation. Therefore, MD simulation-based quantitative assessment of designed variants greatly enhanced the predictive accuracy of computational enzyme design tools and should facilitate the construction of artificial enzymes with high catalytic activities toward non-natural substrates.
Xie D, Tian Y, Cao L, Guo P, Cai Z, Zhou J Front Pharmacol. 2025; 16:1545791.
PMID: 39981188 PMC: 11841475. DOI: 10.3389/fphar.2025.1545791.
Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction.
Maani Z, Farajnia S, Rahbarnia L, Zadeh Hosseingholi E, Khajehnasiri N, Mansouri P J Mol Struct. 2022; 1272:134160.
PMID: 36128074 PMC: 9479519. DOI: 10.1016/j.molstruc.2022.134160.
Recent Developments in Free Energy Calculations for Drug Discovery.
King E, Aitchison E, Li H, Luo R Front Mol Biosci. 2021; 8:712085.
PMID: 34458321 PMC: 8387144. DOI: 10.3389/fmolb.2021.712085.
Huang X, Pearce R, Omenn G, Zhang Y Int J Mol Sci. 2021; 22(13).
PMID: 34209110 PMC: 8269196. DOI: 10.3390/ijms22137060.
Ong E, Huang X, Pearce R, Zhang Y, He Y Comput Struct Biotechnol J. 2021; 19:518-529.
PMID: 33398234 PMC: 7773544. DOI: 10.1016/j.csbj.2020.12.039.